Literature DB >> 30009317

Erythema and induration of the Bacillus Calmette-Guérin site for diagnosing Kawasaki disease.

Ann Loh1, Phek Hui Jade Kua2, Ze Lei Tan3.   

Abstract

INTRODUCTION: Kawasaki disease (KD) is a challenging diagnosis. Erythema and induration of the Bacillus Calmette-Guérin (BCG) site is increasingly recognised as a significant clinical clue. However, there is little data to support its specificity for KD as compared to other febrile illnesses. We aimed to evaluate BCG reaction or induration as a diagnostic tool for KD.
METHODS: A retrospective case-controlled study of patients discharged with a diagnosis of KD from 2007 to 2010 was conducted. Another group of patients admitted over the same period for possible KD, but later found not to have KD, served as control.
RESULTS: Significantly more infants with KD (69.7%) had BCG site changes than older children (27.8%; p < 0.001). It also presented earlier in the course of KD; < 5 days (53.3%) compared to ≥ 5 days of fever (30.0%; p < 0.001). Positive predictive value of BCG site reaction or induration for KD was 90.8% (95% confidence interval [CI] 0.819-0.962) for infants and 96.2% (95% CI 0.868-0.995) for older children. The prevalence rate of changes at the BCG site was 9.9% among patients with non-KD febrile illnesses and 42.6% among patients with KD.
CONCLUSION: BCG site reaction or induration is a useful clinical clue for the diagnosis of KD in both infants and older children, with a higher prevalence in infants. Physicians should consider KD in children with febrile illness and redness or crust formation at the BCG site, especially in view of low rates of BCG reaction or induration in non-KD febrile illnesses. Copyright: © Singapore Medical Association.

Entities:  

Keywords:  BCG inoculation site; BCG reactivation; Kawasaki disease

Mesh:

Substances:

Year:  2018        PMID: 30009317      PMCID: PMC6395842          DOI: 10.11622/smedj.2018084

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  16 in total

1.  BCG site inflammation: a useful diagnostic sign in incomplete Kawasaki disease.

Authors:  Debbie Chalmers; Jenny G Corban; Philip P C Moore
Journal:  J Paediatr Child Health       Date:  2008-09       Impact factor: 1.954

Review 2.  Genetic polymorphisms in Kawasaki disease.

Authors:  Ho-chang Kuo; Wei-chiao Chang
Journal:  Acta Pharmacol Sin       Date:  2011-09-05       Impact factor: 6.150

3.  Two new susceptibility loci for Kawasaki disease identified through genome-wide association analysis.

Authors:  Yi-Ching Lee; Ho-Chang Kuo; Jeng-Sheng Chang; Luan-Yin Chang; Li-Min Huang; Ming-Ren Chen; Chi-Di Liang; Hsin Chi; Fu-Yuan Huang; Meng-Luen Lee; Yhu-Chering Huang; Betau Hwang; Nan-Chang Chiu; Kao-Pin Hwang; Pi-Chang Lee; Li-Ching Chang; Yi-Min Liu; Ying-Ju Chen; Chien-Hsiun Chen; Yuan-Tsong Chen; Fuu-Jen Tsai; Jer-Yuarn Wu
Journal:  Nat Genet       Date:  2012-03-25       Impact factor: 38.330

4.  Kawasaki disease characterized by erythema and induration at the Bacillus Calmette-Guérin and purified protein derivative inoculation sites.

Authors:  Y H Hsu; Y H Wang; W Y Hsu; Y P Lee
Journal:  Pediatr Infect Dis J       Date:  1987-06       Impact factor: 2.129

Review 5.  Diagnosis and therapy of Kawasaki disease in children.

Authors:  A S Dajani; K A Taubert; M A Gerber; S T Shulman; P Ferrieri; M Freed; M Takahashi; F Z Bierman; A W Karchmer; W Wilson
Journal:  Circulation       Date:  1993-05       Impact factor: 29.690

Review 6.  Kawasaki disease--the importance of prompt recognition and early referral.

Authors:  Daniel Golshevsky; Michael Cheung; David Burgner
Journal:  Aust Fam Physician       Date:  2013-07

7.  Bull's eye dermatoscopy pattern at bacillus Calmette-Guérin inoculation site correlates with systemic involvements in patients with Kawasaki disease.

Authors:  Han-Chi Tseng; Ji-Chen Ho; Mindy Ming-Huey Guo; Mao-Hung Lo; Kai-Sheng Hsieh; Wen-Chien Tsai; Ho-Chang Kuo; Chih-Hung Lee
Journal:  J Dermatol       Date:  2016-03-03       Impact factor: 4.005

8.  Human herpes virus type 6 can cause skin lesions at the BCG inoculation site similar to Kawasaki Disease.

Authors:  Yosuke Kakisaka; Tomoichiro Ohara; Saori Katayama; Tasuku Suzuki; Shu Sasai; Naomi Hino-Fukuyo; Shigeo Kure
Journal:  Tohoku J Exp Med       Date:  2012-12       Impact factor: 1.848

Review 9.  Epidemiology of Kawasaki disease in Asia, Europe, and the United States.

Authors:  Ritei Uehara; Ermias D Belay
Journal:  J Epidemiol       Date:  2012-02-04       Impact factor: 3.211

10.  Erythema at BCG Inoculation Site in Kawasaki Disease Patients.

Authors:  Mohammad Sadegh Rezai; Soheila Shahmohammadi
Journal:  Mater Sociomed       Date:  2014-08-26
View more
  4 in total

1.  Reactivation of BCG vaccination scars after vaccination with mRNA-Covid-vaccines: two case reports.

Authors:  Libin Mohamed; Anne Marie Rosendahl Madsen; Frederik Schaltz-Buchholzer; Anne Ostenfeld; Mihai G Netea; Christine Stabell Benn; Poul-Erik Kofoed
Journal:  BMC Infect Dis       Date:  2021-12-20       Impact factor: 3.090

2.  Erythema and Induration of Bacillus Calmette-Guérin Scar Associated With Multisystem Inflammatory Syndrome in Children in Japan: A Case Report.

Authors:  Naoki Tsuboya; Hirotoshi Makino; Yoshihide Mitani; Michiko Ito; Kazunobu Ohya; Mari Morimoto; Ryo Hanaki; Noriko Yodoya; Hiroyuki Ohashi; Hirofumi Sawada; Kenji Sugiyama; Masahiro Hirayama
Journal:  Front Pediatr       Date:  2022-03-11       Impact factor: 3.418

3.  Bacille Calmette-Guérin Site Reactivation of Kawasaki Disease in Infants under 3 Months of Age: Relation with Diagnosis and Prognosis.

Authors:  Da Eun Roh; Jung Eun Kwon; Yeo Hyang Kim
Journal:  Children (Basel)       Date:  2022-06-08

4.  Epidemiologic Features of Kawasaki Disease in Shanghai From 2013 Through 2017.

Authors:  Li-Ping Xie; Wei-Li Yan; Min Huang; Mei-Rong Huang; Sun Chen; Guo-Ying Huang; Fang Liu
Journal:  J Epidemiol       Date:  2019-09-21       Impact factor: 3.211

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.